Browsing by Author "Bar-Or, Amit"
Now showing items 1-4 of 4
-
Long-term safety and efficacy of ozanimod in relapsing multiple sclerosis: Up to 5 years of follow-up in the DAYBREAK open-label extension trial
Cree, Bruce; Selmaj, Krzysztof W.; Steinman, Lawrence; Comi, Giancarlo; Bar-Or, Amit; Arnold, Douglas L; Montalban Gairín, Xavier (SAGE Publications, 2022-10) -
Ozanimod in relapsing multiple sclerosis: Pooled safety results from the clinical development program
Selmaj, Krzysztof W.; Cohen, Jeffrey A; Comi, Giancarlo; Bar-Or, Amit; Arnold, Douglas L; Steinman, Lawrence; Montalban Gairín, Xavier (Elsevier, 2021-06) -
Rapid and sustained B-cell depletion with subcutaneous ofatumumab in relapsing multiple sclerosis: APLIOS, a randomized phase-2 study
Bar-Or, Amit; Wiendl, Heinz; Montalban Gairín, Xavier; Alvarez, Enrique; Davydovskaya, Maria; Delgado, Silvia R (SAGE Publications, 2022-05) -
Serum Neurofilament Light Trajectories and Their Relation to Subclinical Radiological Disease Activity in Relapsing Multiple Sclerosis Patients in the APLIOS Trial
Bar-Or, Amit; Montalban Gairín, Xavier; Hu, Xixi; Kropshofer, Harald; Kukkaro, Petra; Coello, Neva (Springer, 2023-02)